Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FA1AE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $79,864
Award facts
- Contract value 100% obligated
- $79,863.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $79,863.88 delivery order to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on January 6, 2026, for the supply of Dupixent 300 mg/2 ml pen injectors. This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by January 7, 2026. The place of performance is located in Conshohocken, Pennsylvania, where Amerisourcebergen Drug Corp maintains its corporate headquarters. This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at up to $999,999,999.00 through December 2026 and serves as a comprehensive global pharmaceutical support vehicle.
The Dupixent delivery supports military healthcare programs by providing a biologic medication commonly used to treat moderate-to-severe atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps in military beneficiaries. Amerisourcebergen Drug Corp has established itself as a critical vendor for federal medical procurement through its extensive portfolio of pharmaceutical and medical supply deliveries to the Defense Logistics Agency and its Medical Supply Chain. The company's demonstrated capability to fulfill competitive federal procurement requirements, combined with its significant master contract vehicle with DLA Troop Support Medical, positions it as a key supplier for military healthcare systems and other government agencies requiring specialized pharmaceutical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FA1AE?
SPE2DR26FA1AE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FA1AE worth?
The government has obligated $79,864 on SPE2DR26FA1AE.
Is contract SPE2DR26FA1AE an order under another contract?
Yes. SPE2DR26FA1AE is a delivery order under SPE2DR25D2100, an indefinite delivery contract.
Was contract SPE2DR26FA1AE competed?
The extent of competition for SPE2DR26FA1AE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award